Published January 1, 2021
| Version v1
Journal article
Open
Development of oral aprepitant-loaded chitosan-polyethylene glycol-coated cyclodextrin nanocapsules: formulation, characterization, and pharmacokinetic evaluation
Creators
- 1. Hacettepe Univ, Dept Pharmaceut Technol, Fac Pharm, Ankara, Turkey
- 2. Aalborg Univ, Dept Chem & Biosci, Aalborg, Denmark
- 3. Hacettepe Univ, Dept Pharmacol, Fac Med, Ankara, Turkey
- 4. Hacettepe Univ, Dept Hematol, Fac Med, Ankara, Turkey
- 5. Hacettepe Univ, Dept Analyt Chem, Fac Pharm, Ankara, Turkey
Description
Purpose Aprepitant (APRT), a selective neurokinin 1 antagonist, is clinically used in the prevention of acute and delayed chemotherapy-induced nausea and vomiting. The low solubility of APRT, which limits its oral bioavailability, is overcome by nanonization. This study aimed to design and evaluate novel in vitro and in vivo chitosan (CS)-polyethylene glycol (PEG)-coated cyclodextrin (CD) nanoparticles and nanocapsules to enhance the solubility and oral bioavailability of APRT.
Files
bib-0b420214-936d-4182-aa3b-c99e882f4bc9.txt
Files
(330 Bytes)
| Name | Size | Download all |
|---|---|---|
|
md5:169c8f55676c326d7ae1976c59947048
|
330 Bytes | Preview Download |